An Open Label, Phase 1 Study to Assess the Effect of Food on Bioavailability for an Investigational Capsid Inhibitor in Healthy Adult Participants
Latest Information Update: 25 Feb 2025
At a glance
- Drugs VH 4011499 (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors ViiV Healthcare
Most Recent Events
- 18 Feb 2025 Status changed from recruiting to completed.
- 20 May 2024 Status changed from not yet recruiting to recruiting.
- 18 Apr 2024 New trial record